For Corporate Purchasing Managers, Technical Directors & Operations Leaders seeking fast, cost‑effective antigen design and GMP‑certified production.
You know that bringing a melanoma vaccine from concept to clinical trial is a race against time and budget. Yet many organizations hit the same roadblocks:
Data point: A 2025 industry survey of 312 biotech firms reported that 38 % of projects missed their Phase I start date due to supply‑chain bottlenecks.
Global Technology Co., Ltd combines a Powerful Factory network, ISO‑9001 & GMP certification, and a dedicated OEM/ODM design team** to deliver:
| Parameter | Standard Offering | Custom Option |
|---|---|---|
| Peptide Length | 8‑30 aa | ≤ 50 aa (via solid‑phase synthesis) |
| Purity (HPLC) | ≥ 95 % | ≥ 98 % (additional polishing) |
| Batch Size | 10 mg‑500 mg | 1 g‑10 kg (scale‑up) |
| Release Testing | Identity, Purity, Endotoxin, Sterility | All above + Potency (ELISA), Stability (90 days) |
| Regulatory Docs | Certificate of Analysis, GMP Batch Record | Full IND‑ready dossier (DMF, CMC) |
Case 1 – US Biotech Startup (2024): Needed a neo‑antigen library for a personalized melanoma vaccine. We delivered 150 custom peptides (≤ 30 aa) within 7 weeks, cutting projected costs from $420 k to $310 k (26 % saving). The IND filing was accepted without major CMC queries.
Case 2 – European Academic Consortium (2025): Required GMP‑grade Melan‑A peptide for a Phase I trial. Our fast‑track line produced 250 mg at 99 % purity in 5 weeks, enabling trial enrollment 3 months ahead of schedule.
Case 3 – Asian Pharma Partner (2023): Needed bulk peptide for pre‑clinical toxicology. We scaled to 5 kg with a 35 % reduction in freight cost by using consolidated container shipping.
Standard sequences (8‑30 aa) are delivered in 6‑8 weeks from design sign‑off. Custom longer peptides add 1‑2 weeks for synthesis optimization.
Yes. We supply a full CMC package including DMF, Certificate of Analysis, GMP batch records, stability data, and sterility reports aligned with FDA, EMA, and PMDA requirements.
Our in‑house bio‑informatics team can design neo‑antigens based on your tumor‑sequencing data, perform epitope prediction, and deliver **custom‑synthesized peptides** under a confidential NDA.
All GMP batches are packed in validated insulated containers with dry ice and accompanied by a temperature‑monitoring data logger. We partner with UPS Cold‑Chain for door‑to‑door delivery.
We accept T/T, L/C, PayPal Business, and corporate credit cards. For orders > 2 kg, a 30 % deposit with balance on shipment is standard; credit terms (Net 30) can be arranged for qualified accounts.

Absolutely. Our scientific liaison team offers **30 days of free technical assistance**, including formulation advice, stability testing guidance, and regulatory clarification.
Act now to lock in the 2026 price before the anticipated 12 % annual increase in raw material costs. We guarantee:
All quotations are valid for 30 days. Stock is limited to 150 kg of GMP‑grade peptide per quarter.
James Patel, Senior Procurement Manager, NovaCure – “The **speed** of delivery saved us three months of pre‑clinical work. Their **transparent cost breakdown** made budgeting effortless.”
Sofia Rossi, Head of Immunotherapy, MedTech Italia – “We appreciated the **custom epitope design** service. The peptide’s **stability** (> 180 days at –20 °C) exceeded our expectations.”
Michael Chen, CTO, ImmunoGenix – “Global Technology’s **ISO‑9001** audit report gave our compliance team confidence for FDA filing. The **risk‑free pilot** was a decisive factor.”
Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Trusted by Global Leaders – Logos & Certifications
Customer Testimonials
Regulatory & Quality Certifications
Areca-alkaloid Alpha-amanitin Body-odor-control-cosmetic-active Diagnostic-pentagastrin-peptide-manufacturer